Apeiron Investment Group Ltd. 4
4 · ATAI Life Sciences N.V. · Filed Oct 2, 2025
Insider Transaction Report
Form 4
Apeiron Investment Group Ltd.
10% Owner
Transactions
- Conversion
Common Shares
2025-09-30+2,367,200→ 53,412,414 total(indirect: By Apeiron Investment Group Ltd.) - Conversion
Convertible Notes
2025-09-30−147,950→ 0 total(indirect: By Apeiron Investment Group Ltd.)From: 2024-04-15Exp: 2025-09-30→ Common Shares (2,367,200 underlying)
Holdings
- 1,799,302(indirect: By Apeiron Presight Capital Fund II, L.P.)
Common Shares
Footnotes (2)
- [F1]The conversion price for the Convertible Notes is EUR 17.00 per note.
- [F2]The Convertible Notes were acquired in exchange for convertible notes issued by ATAI Life Sciences AG with substantially similar terms and economics.